While investigational efforts were more focused on the role of S1PR3 in leukemia and myelopoiesis, the study found that S1PR3 over-expression in human HSCs favored CD33+ myeloid and CD41+ megakaryocytic lineage commitment at the expense of erythroid and lymphoid lineage commitment [116]. The gene discussed is S1PR3; the disease is leukemia.